Skip to main
We’re doing some system maintenance
  1. /
  2. Stocks
  3. /
  4. Artelo Biosciences Inc
ARTL

Buy ARTL Stock

ARTL
See ARTL stock price and Buy/Sell Artelo Biosciences Inc with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing
ARTL

Artelo Biosciences Inc (ARTL)

About Artelo Biosciences Inc (ARTL)

Artelo Biosciences, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of therapeutics that target lipid-signaling pathways, including the endocannabinoid system. Its product candidate pipeline includes ART27.13-Synthetic Cannabinoid Agonist, ART26.12-FABP5 inhibitor, and ART12.11-Synthetic CBD Cocrystal. The company was founded by James Manley on May 2, 2011 and ...Read more
Market Cap
$9.97M
1 Year High
$19.80
Volume
9.14k
1 Year Low
$3.11
Price to Earnings Ratio
Open
$3.55
Dividend Rate
High
$3.60
Dividend Yield
Low
$3.47

Community

People who own or watch ARTL stock

ARTL Price Targets

What analysts think ARTL stock price will be.
$3.56
$46.25
1,199.2% Upside
$2$49

ARTL Stock Rating

What analysts recommend for ARTL stock, on a scale from 1(buy) to 5(sell).
Strong Buy1 / 5
BuyHoldSell

ARTL Stock Earnings

The value each ARTL share was expected to gain vs. the value that each ARTL share actually gained.
Expected
Actual

ARTL Stock News

Frequently Asked Questions (FAQ)

As of Sep 28, 2022, the market cap for ARTL stock is $9.97M

The 52-week high for ARTL stock is $19.80. The current ARTL stock price $3.56 is 82.02% below its 52-week high

The 52-week low for ARTL stock is $3.11. The current ARTL stock price $3.56 has increased 12.64% from its 52-week low

No, the ARTL stock does not pay dividends to its shareholders

The target price for ARTL stock is $46.25 based on the average of what a group of analyst think ARTL stock could be worth at a future date. This is not a prediction by Public.com

Buy ARTL Stock

ARTL
See ARTL stock price and Buy/Sell Artelo Biosciences Inc with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing

Community

People who own or watch ARTL stock
  • JL007 avatar
  • MDaranikone978 avatar
  • ledesma1968 avatar
  • Fatprofit avatar
  • normanj avatar
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2022 Public Holdings, Inc. All Rights Reserved.

Market data powered by Xignite.

Securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings Inc. (“Public Holdings”). This is not an offer, solicitation of an offer or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Cryptocurrency execution and custody services are provided by Apex Crypto LLC (NMLS ID 1828849) through a software licensing agreement between Apex Crypto LLC and Public Crypto LLC. Apex Crypto is not a registered broker-dealer or a member of SIPC or FINRA. Cryptocurrencies are not securities and are not FDIC or SIPC insured. Apex Crypto is licensed to engage in virtual currency business activity by the New York State Department of Financial Services. Please ensure that you fully understand the risks involved before trading: Legal Disclosures

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S. listed securities electronically. Keep in mind, that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.